Please assess the completion status of the following clinical trial:

Trial Title: PleuraSeal Pivotal Study (US)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Elective pulmonary lobectomy, segmental and/or wedge resection in one or more lobes via an open thoracotomy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PleuraSeal Sealant Device (Type: EXPERIMENTAL): None
- Control (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).